Theraclion Obtains FDA Authorization for Sonovein®

Theraclion received FDA authorization for its Sonovein® system, which uses high-intensity focused ultrasound to treat varicose veins without incisions or anesthesia. The authorization allows the company to bring its echotherapy technology to U.S. hospitals and clinical treatment centers. The article reports no financial figures or stock-price impact.